Source:http://linkedlifedata.com/resource/pubmed/id/11834677
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-2-8
|
pubmed:abstractText |
One of the major goals of bronchodilator therapy in patients with COPD is to decrease airflow limitation in the airways and, as a consequence, improve dyspnea and exercise tolerance. The focus of this systematic review is to assess the effects of treatment with beta-agonists, anticholinergics, and theophyllines on dyspnea, and steady-state and incremental exercise capacity. Thirty-three, double-blind, randomized, placebo-controlled studies written in English were selected. This review shows that approximately half of the studies showed a significant effect of bronchodilator therapy on exercise capacity. Anticholinergic agents have significant beneficial effects in the majority of studies, especially when measured by steady-state exercise protocols. There is a trend toward a better effect of high-dose compared to low-dose anticholinergics. Short-acting beta(2)-mimetics have favorable effects on exercise capacity in more than two thirds of the studies; surprisingly, the situation is less clear for long-acting beta(2)-agents. The majority of the results of the published reports on theophyllines and their effects on exercise are negative. Direct comparisons of different classes of bronchodilators have not been made in a sufficient number of studies for a rational preference. The addition of a second bronchodilator has no proven advantage for improving exercise test results, but this has not been studied extensively and not in sufficiently large studies. The majority of studies reporting a measure of dyspnea found improvements, even in the absence of improvement in exercise capacity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0012-3692
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
597-608
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11834677-Adrenergic beta-Agonists,
pubmed-meshheading:11834677-Bronchodilator Agents,
pubmed-meshheading:11834677-Cholinergic Antagonists,
pubmed-meshheading:11834677-Exercise Tolerance,
pubmed-meshheading:11834677-Humans,
pubmed-meshheading:11834677-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:11834677-Theophylline
|
pubmed:year |
2002
|
pubmed:articleTitle |
A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD.
|
pubmed:affiliation |
Department of Pulmonary Diseases, University Hospital Groningen, Groningen, The Netherlands. J.J.W.Liesker@int.azg.nl
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|